The Patent Finder

Medshine Discovery Inc.

36 patents currently held · Updated Nov 16, 2026
79 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Aug 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 23, 2026
    The maintenance fee for Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor (US 11,655,248) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
  • 2 fees due Dec 13 to 20, 2026 · next Dec 13
  • 2 fees due Jan 4 to 18, 2027 · next Jan 4
  • 1 fee due May 14, 2027
    The maintenance fee for Heterocyclic compound (US 11,814,371) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Bicyclic compound that acts as CRBN protein regulator (US 11,905,276) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 1 fee due Sep 30, 2027
    The maintenance fee for Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases (US 10,604,513) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,280,229Linkers and their application towards ADC
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,183,915Axially Chiral Isomers, and Preparation Methods Therefor and Pharmaceutical Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,717,720Modified compound of andrographolide
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,604,513Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,662,189PDE4 inhibitor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,040,984Quinazoline compound for EGFR inhibition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,466,024Bicylic compound acting as an inhibitor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,198,686Crystal form and salt form of pyridone compound and preparation method therefor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,572,372Anti-hbvtetrahydroisoxazolo[4,3-c]pyridine Compounds
In force
 · High confidence
In forceHigh confidence
US 11,623,923Uracil compound as c-MET/AXL inhibitor
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 36 patents shown.
Pro members see all 36.
Pro members: see all 36 patents
Also on record, not counted in the 36: 79 patents in force now held by others · 14 lapsed for an unpaid fee · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

24 pending · 4 abandoned · 40 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited